Summary by Moomoo AI
On 18 March 2024, under Rule 22 of the Hong Kong Code of Companies Acquisition and Mergers, Yichang Dongguang Changjiang Pharmaceutical Co., Ltd. (Dongsun Changjiang Pharmaceuticals) made a share transaction disclosure regarding its privatization transaction. The disclosure documents show that CICC Financial Trading Limited conducted related securities transactions on March 15, 2024, which included the purchase and sale of 200,000 shares each with a transaction amount of $2,110,812.09 and $2,111,526.62, respectively, with trading prices of $10.5541 and $10.5576 per share. CICC Financial Trading Limited is an exempt self-dealing seller associated with the Contracting Party and the transaction is conducted for its own account.